Bristol Myers Squibb (BMY) Short-term Investments (2009 - 2026)
Bristol Myers Squibb (BMY) recorded Short-term Investments of $2.35 billion in Q2 2026, up 133.6% from $1 billion a year earlier and up 157.1% from the prior quarter.
Powered by 
Analysis
Bristol Myers Squibb (BMY) Short-term Investments (2009 - 2026) Analysis & Trends
At the end of FY2025, Bristol Myers Squibb reported Short-term Investments of $464 million, down 9.6% from FY2024.
- Annual Short-term Investments has a five-year compound annual growth rate of -18.4% (FY2020 to FY2025).
- Across earlier years, Short-term Investments came in at $513 million in FY2024 (-37.1%), $816 million in FY2023 (+527.7%), $130 million in FY2022 (-95.6%) and $2.99 billion in FY2021 (+132.5%).
- The Q2 2026 figure is the highest quarterly Short-term Investments since Q2 2022.
- On a year-over-year basis, Short-term Investments rose in six of the last eight quarters, with growth averaging 91.6%.
- Peak year-over-year performance for Short-term Investments in the last five years was growth of 527.7% in Q4 2023, against a decline of 95.6% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $912 million (Q1 2026), $464 million (Q4 2025) and $776 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Bristol Myers Squibb | 128.71 Bn | 79.98 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.35 Bn |
| Mar 31, 2026 | 912.00 Mn |
| Dec 31, 2025 | 464.00 Mn |
| Sep 30, 2025 | 776.00 Mn |
| Jun 30, 2025 | 1.00 Bn |
| Mar 31, 2025 | 907.00 Mn |
| Dec 31, 2024 | 513.00 Mn |
| Sep 30, 2024 | 204.00 Mn |
| Jun 30, 2024 | 360.00 Mn |
| Mar 31, 2024 | 340.00 Mn |
| Dec 31, 2023 | 816.00 Mn |
| Sep 30, 2023 | 171.00 Mn |
| Jun 30, 2023 | 358.00 Mn |
| Mar 31, 2023 | 274.00 Mn |
| Dec 31, 2022 | 130.00 Mn |
| Sep 30, 2022 | 1.29 Bn |
| Jun 30, 2022 | 2.48 Bn |
| Mar 31, 2022 | 2.60 Bn |
| Dec 31, 2021 | 2.99 Bn |
| Sep 30, 2021 | 2.12 Bn |
API Access
Bristol Myers Squibb Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=BMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();